openPR Logo
Press release

Vaginitis Therapeutics Market 2019 Competitive Analysis: Lupin, Pfizer Inc, Sanofi, Teva Pharmaceutical Industries Ltd, Bausch Health, DARÉ BIOSCIENCE, INC

11-11-2019 09:33 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Vaginitis Therapeutics Market

Vaginitis Therapeutics Market

The new report titled "Global Vaginitis Therapeutics Market" By Types (Bacterial Vaginosis, Trichomoniasis, Vulvovaginal Candidiasis and Others), Drug Class (Anti-fungal, Anti-bacterial, Hormone and Others), Medication Type (Over-The-Counter (OTC), Prescription (Rx)), Route of Administration (Oral, Topical), End- Users (Hospitals, Specialized Gynecology Centers and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Global Vaginitis Therapeutics Market is expected to grow at a growing CAGR of 8.9 %in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Get Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-vaginitis-therapeutics-market

Some of the major competitors currently working in the global vaginitis therapeutics market are Lupin, Pfizer Inc, Sanofi, Teva Pharmaceutical Industries Ltd, Bausch Health, DARÉ BIOSCIENCE, INC, Hennepin Life Sciences, LLC, Starpharma Holdings Limited, PhagoMed Biopharma GmbH, TenNor Therapeutics Ltd, Enzo Biochem Inc, Tolmar Pharmaceuticals, Inc, Perrigo Company plc and others.

Market Definition:

Vaginitis is an inflammation of the vagina or vulva that results in a thick, white, cottage cheese-like vaginal discharge that is watery and usually odorless, itching and redness of the vulva and vagina and pain with urination or sex. It usually caused by an infection, lack of estrogen hormone and among others.

Market Drivers

An ongoing clinical trial conducted by many pharmaceuticals industries is propelling the growth of this market

Increase in use of antibiotics is likely to boost the market growth

High demand of disease-specific novel treatment can also act as a market driver

The competitive scenario of the market and strategic collaborations may boost the market position

Market Restraints

Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market

Low healthcare budget in some developing countries is hamper the market growth
Patent expiration of branded drugs and introduction of generics is also hinders the market growth

Segmentation: Global Vaginitis Therapeutics Market

By Types

Bacterial Vaginosis
Trichomoniasis
Vulvovaginal Candidiasis
Others

By Drug Class

Anti-fungal

Miconazole
Clotrimazole
Terconazole
Others

Anti-bacterial

Clindamycin
Ceftriaxone
Erythromycin
Others

Hormone
Others

By Medication Type

Over-The-Counter (OTC)
Prescription (Rx)

By Route of Administration

Oral
Topical

By End Users

Hospitals
Specialized Gynecology Centers
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies

By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-vaginitis-therapeutics-market

Key Developments in the Market:

In December 2018, DARÉ BIOSCIENCE, INC entered into an agreement with Hammock Pharmaceuticals, Inc., TriLogic Pharma LLC and MilanaPharm. Under the terms of the agreement, DARÉ BIOSCIENCE, INC acquired the global rights to MP-101 for the treatment of bacterial vaginosis (BV), as well as the rights to utilize the underlying proprietary hydrogel drug delivery technology for any vaginal or urological application in humans. The acquisition of MP-101 broaden company’s woman healthcare portfolio and advances the treatment options for patient suffering from this condition

In September 2017, Symbiomix Therapeutics a subsidiary of Lupin received approval from the FDA for Solosec (secnidazole), 5-nitroimidazole antibiotic, available in 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. The approval of Solosec provides oral treatment and represents the major advance in the treatment of these patients through targeted mode of action.

Competitive Analysis:

Global vaginitis therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global vaginitis therapeutics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global vaginitis therapeutics market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-vaginitis-therapeutics-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaginitis Therapeutics Market 2019 Competitive Analysis: Lupin, Pfizer Inc, Sanofi, Teva Pharmaceutical Industries Ltd, Bausch Health, DARÉ BIOSCIENCE, INC here

News-ID: 1864586 • Views: 649

More Releases from Data Bridge Market Research

Tinnitus Drug Market 2020 : Potential Growth, Challenges, Industry Analysis | Ke …
Tinnitus Drug Market study analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, distributors and Porter's Five Forces Analysis. It also defines, explains and forecasts the market by various segments such as type, application, end-users, and region. In this large scale industry analysis document, the leading key players are strategically profiled and their growth strategies are also thoroughly analyzed. Tinnitus
Telemental Health Market Size, Share, Industry Trends and Forecast 2026 | Key Pl …
Telemental Health Market report provides an overview of important sections, players included, years considered, objective of the market study, and scope of the study. The report undertakes almost all important regions including North America and MEA, and also provides a complete analysis of their CAGR, market size, future growth opportunities, and other vital factors. The segmentation study identifies leading segments and explains key factors supporting their growth in the global
Teeth Whitening Market 2020 Key Business Strategies by Leading Industry Players …
Teeth Whitening Market 2020 research report offers information on production development, market sales, regional trade, investment calculation, investment opportunity, trade outlook, policy, regional market and other important characteristic of the wire and cable market. This market report also encompasses a far-reaching research on the current conditions of the Healthcare industry, potential of the market in the present and the future prospects. Only authentic tools of market analysis are used
Targeted Delivery Drugs Market 2019-2026 | Know about Emerging Growth with Top P …
This Global Targeted Delivery Drugs Market research analysis report starts with a basic introduction of the 2019 market segmentation, future scenario, Pharmaceutical industry growth rate, and industrial opportunities to 2026. The report gives out an outlook of the business chain structure and explains the industry environment, then analyzes the market size and forecast by product, region and market application. This business research report helps in growing sales with new thinking,

All 5 Releases


More Releases for Therapeutics

Lipodystrophy Therapeutics- Pipeline Analysis 2018 | Ionis Pharmaceuticals, Inc. …
Lipodystrophy is a rare medical condition which involves problems with fat production, usage, and storage. It is categorized into two types; congenital and acquired lipodystrophy. Download the sample report @ https://www.pharmaproff.com/request-sample/1077 Congenital lipodystrophies include congenital generalized lipodystrophy, familial partial lipodystrophy, and marfanoid progeroid lipodystrophy syndrome; while acquired lipodystrophy includes acquired partial lipodystrophy, acquired generalized lipodystrophy, centrifugal abdominal lipodystrophy, lipoatrophia annularis, localized lipodystrophy and HIV-associated lipodystrophy. Get the detailed analysis @ https://www.pharmaproff.com/report/lipodystrophy-therapeutics-pipeline-analysis The
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Pontine Glioma Therapeutics- Pipeline Analysis 2018 | Y-mAbs Therapeutics, Inc.
Pontine glioma is a malignant tumour which develops from the brain stem cells. Based on the grade of growth, it is categorized into anaplastic astrocytomas and glioblastoma multiforme (GBM). Download the sample report @ https://www.pharmaproff.com/request-sample/1117 Pontine glioma is more prevalent in children than adults. The common signs and symptoms of pontine glioma are squints, swallowing problems, slurred speech, facial weakness, abnormal gait, difficulty in writing and changes in personality and behaviour.
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology
Bone Degeneration Therapeutics Market
Bone degeneration is characterized by deterioration of articular cartilage covering the joints. Cartilage aids free movement of the joint without any resistance. Reduction in flexibility of the joint due to deterioration of cartilage leads to inflammation, compressed nerves, and pain. Aging is one of the natural causes of bone degeneration, which is also fueled by several conditions such as injuries, congenital disorders, diabetes, and obesity. Symptoms of degenerative bone disorders
Global Dyslipidemia Therapeutics Market
Dyslipidemia is one of the metabolic disorder, which is described by unbalanced level and thickness of lipoproteins and triglycerides. The disorder also includes protein deficiency and over production. These disorders can be caused by increase in the serum total cholesterol, triglyceride concentrations, and low-density lipoprotein (LDL) cholesterol, and a decrease in the high-density lipoprotein (HDL) cholesterol concentration. These condition are mainly associated with cardiovascular or coronary heart disease. The other